VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 126 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,125,525 | -35.0% | 2,941,690 | +0.8% | 0.00% | -25.0% |
| Q2 2023 | $69,427,999 | +13.6% | 2,918,369 | +21.5% | 0.00% | +33.3% |
| Q1 2023 | $61,102,097 | -43.9% | 2,401,812 | -35.5% | 0.00% | 0.0% |
| Q4 2022 | $108,847,560 | +350.3% | 3,726,380 | +216.2% | 0.00% | +50.0% |
| Q3 2022 | $24,172,000 | +359.1% | 1,178,549 | +159.0% | 0.00% | – |
| Q2 2022 | $5,265,000 | +331.6% | 455,065 | +589.5% | 0.00% | – |
| Q1 2022 | $1,220,000 | +81.3% | 66,000 | +93.9% | 0.00% | – |
| Q4 2021 | $673,000 | +71.7% | 34,041 | +42.8% | 0.00% | – |
| Q3 2021 | $392,000 | +94.1% | 23,841 | +115.9% | 0.00% | – |
| Q2 2021 | $202,000 | – | 11,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |